Brunner, Fabian J. http://orcid.org/0000-0003-0335-8625
Waldeyer, Christoph
Zengin-Sahm, Elvin
Kondziella, Christoph
Schrage, Benedikt
Clemmensen, Peter
Westermann, Dirk
Blankenberg, Stefan
Seiffert, Moritz http://orcid.org/0000-0002-3940-9079
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 24 February 2022
Accepted: 8 April 2022
First Online: 29 April 2022
Declarations
:
: BS reports speaker fees from Abiomed and AstraZeneca, outside of the submitted work; DW reports honoraria for lectures Abiomed, AstraZeneca, Bayer, Berlin-Chemie, Daichii, Novartis, and Medtronic, outside the submitted work; SB has received research funding from Abbott Diagnostics, Bayer, SIEMENS, Singulex and Thermo Fisher, he received honoraria for lectures from Abbott, Abbott Diagnostics, Astra Zeneca, Bayer, AMGEN, Medtronic, Pfizer, Roche, SIEMENS Diagnostics, SIEMENS, Thermo Fisher and as member of Advisory Boards and for consulting for Bayer, Novartis and Thermo Fisher, outside the submitted work; MS reports non-financial support from Abbott Vascular, personal fees from Abiomed, personal fees from AstraZeneca, personal fees from Bayer Healthcare, non-financial support from Biotronik, personal fees from Boehringer Ingelheim, personal fees and non-financial support from Boston Scientific, personal fees from Bristol-Myers Squibb, non-financial support from Edwards Lifesciences, non-financial support from Nicolai Medizintechnik, non-financial support from OrbusNeich Medical, grants and personal fees from Philips, personal fees from Medtronic, personal fees from Amgen, personal fees from Shockwave Medical, personal fees from Daichii Sankyo, personal fees from Pfizer, personal fees from Siemens Healthineers, outside the submitted work; FJB, CW, EZS, CK, and PC have no conflicts of interest to declare.